Prostate News Archive
19-Jan-2011
Treatment tested in N.O. helps those with recurring prostate cancer
NEW ORLEANS -- prostate cancer is the second most common cause of cancer death in men, taking the lives of 30,000 men in the U.S. each year, according to the American Cancer Society. Caught early, before it spreads, it is very curable. Now new technology to treat prostate cancer is being tested right here in New Orleans. When Stanley Dubroca, a 62-year-old who lives in Metairie, was only in his ... Scientists stop prostate cancer spreading in mice
Melbourne researchers have discovered a new way to halt the spread of prostate cancer, a disease that kills more than 3000 Australian men each year. Prostate cancer screening test under scrutiny
The PSA test is one of the most widely used screening tests in the United States for prostate cancer, which is the second leading cause of death among American men. Yet several randomized studies have reported little or no survival benefit for men who get the test. MicroRNA suppresses prostate cancer stem cells and metastasis
A small slice of RNA inhibits prostate cancer metastasis by suppressing a surface protein commonly found on prostate cancer stem cells. miR-34a targets a surface protein common to cancer stem cells and associated with tumor development and metastasis. When the micro RNA stifles CD44, it inhibits formation of prostate stem cells. Researchers blocked tumor formation, shrunk tumors and inhibited ... Prostate-shrinking drug may help detect cancer
Avodart produces more accurate readings on PSA tests,researchers at Washington University find.
Back to Prostate News Archive
